Detalhe da pesquisa
1.
[Challenges and Prospects of a Specific Clinical Study].
Gan To Kagaku Ryoho
; 51(1): 1-6, 2024 Jan.
Artigo
em Japonês
| MEDLINE | ID: mdl-38247083
2.
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third edition.
Int J Clin Oncol
; 28(10): 1237-1258, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37599324
3.
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with high tumor mutational burden tumors.
Int J Clin Oncol
; 28(8): 941-955, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37300720
4.
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors.
Int J Clin Oncol
; 28(7): 827-840, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37212982
5.
[Medical ethics and research ethics].
Rinsho Ketsueki
; 62(8): 1343-1348, 2021.
Artigo
em Japonês
| MEDLINE | ID: mdl-34497225
6.
Japan Society of Clinical Oncology provisional clinical opinion for the diagnosis and use of immunotherapy in patients with deficient DNA mismatch repair tumors, cooperated by Japanese Society of Medical Oncology, First Edition.
Int J Clin Oncol
; 25(2): 217-239, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31286289
7.
Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology.
Int J Clin Oncol
; 25(3): 403-417, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31974683
8.
A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study).
Int J Clin Oncol
; 24(10): 1284-1291, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31127479
9.
A multi-institutional observational study on the effects of three-dimensional radiotherapy and weekly 40-mg/m2 cisplatin on postoperative uterine cervical cancer patients with high-risk prognostic factors.
Int J Clin Oncol
; 24(5): 575-582, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30580379
10.
Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma.
Ann Surg Oncol
; 25(9): 2756-2766, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29971677
11.
Proposal for a Risk-Based Categorization of Uterine Carcinosarcoma.
Ann Surg Oncol
; 25(12): 3676-3684, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30105438
12.
Significance of venous thromboembolism in women with uterine carcinosarcoma.
Gynecol Oncol
; 148(2): 267-274, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29248197
13.
Survival outcome of women with stage IV uterine carcinosarcoma who received neoadjuvant chemotherapy followed by surgery.
J Surg Oncol
; 117(3): 488-496, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29044542
14.
Pazopanib Maintenance Therapy in East Asian Women With Advanced Epithelial Ovarian Cancer: Results From AGO-OVAR16 and an East Asian Study.
Int J Gynecol Cancer
; 28(1): 2-10, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26588236
15.
Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcoma.
Gynecol Oncol
; 145(1): 78-87, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28215838
16.
Salvage chemotherapy with taxane and platinum for women with recurrent uterine carcinosarcoma.
Gynecol Oncol
; 147(3): 565-571, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29056442
17.
Tumor characteristics and survival outcomes of women with tamoxifen-related uterine carcinosarcoma.
Gynecol Oncol
; 144(2): 329-335, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27931750
18.
Feasibility Study of Adjuvant Chemotherapy Using Taxane Plus Carboplatin for High-Risk Patients With Uterine Cervical Non-Squamous Cell Carcinoma After Radical Hysterectomy.
Int J Gynecol Cancer
; 26(3): 561-7, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26825829
19.
Clinical efficacy of nedaplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a Tohoku Gynecologic Cancer Unit Study.
Int J Clin Oncol
; 21(4): 735-740, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26782958
20.
Phase II trial of oral etoposide plus intravenous irinotecan in patients with platinum-resistant and taxane-pretreated ovarian cancer (JCOG0503).
Gynecol Oncol
; 136(2): 218-23, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25449313